This case-control study compares the levels of plasma coenzyme Q10 in patients with multiple system atrophy with those in age-, sex-, and COQ2 genotype–matched controls.
In a phase III randomized, placebo-controlled, double-blind clinical trial, Beal and coauthors examine whether coenzyme Q10 could slow disease progression in early Parkinson disease. See also the editorial by Schapira and Patel.
You currently have no searches saved.
Create a personal account or sign in to: